| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $34.4M | — | -0.9% |
| Cost of Revenue | $22.7M | — | -17.0% |
| Gross Profit | $11.7M | — | +58.6% |
| R&D Expense | $5.5M | — | +32.8% |
| SG&A Expense | $29.2M | — | +28.6% |
| Operating Income | -$24.3M | — | -14.4% |
| Interest Expense | $317K | — | -93.8% |
| Pre-tax Income | -$56.7M | — | +8.4% |
| Income Tax | $14K | — | -44.0% |
| Net Income | -$56.8M | — | +8.4% |
| EPS (Basic) | -$0.12 | — | +52.0% |
| EPS (Diluted) | -$0.12 | — | +52.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $100.7M | +15.6% | -6.4% |
| Accounts Receivable | $22.8M | +0.5% | -34.0% |
| Current Assets | $394.0M | +19.2% | +165.8% |
| Total Assets | $861.7M | -3.7% | +117.4% |
| Current Liabilities | $64.8M | -65.1% | -27.3% |
| Long-term Debt | $16.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.0M | — | -170.1% |
| Capital Expenditures | $319K | — | +298.8% |
| Investing Cash Flow | $32.7M | — | +2119.9% |
| Financing Cash Flow | -$783K | — | -101.2% |
| Free Cash Flow | -$18.3M | — | -171.6% |
| -83.6% |
| Total Liabilities | $71.3M | -74.8% | -64.1% |
| Stockholders' Equity | $790.4M | +29.2% | +299.6% |